CUE
Cue Biopharma
25.50$
-7.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +350.9% | +107.6% | +81.1% | +579.7% | -160.9% | – | – | +90.3% | -31.6% | -59.2% | |
| – | – | +212.0% | +158.5% | -9.1% | +60.7% | +9.9% | -17.5% | -13.9% | -16.3% | -30.7% | |
| – | +1,101.2% | +707.3% | -2.5% | -12.6% | +50.8% | +15.9% | -17.3% | – | – | – | |
| – | +262.6% | +446.5% | +44.7% | -135.4% | – | -180.7% | – | -362.4% | – | – | |
| – | -31.6% | +133.5% | +53.9% | -97.5% | +1,184.2% | +53.4% | -81.3% | -100.0% | – | +168.2% | |
| – | -35.8% | +133.5% | +1,589.2% | – | +29.3% | +104.4% | -370.2% | – | -99.9% | +134.4% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +23.9% | +195.1% | – | -102.2% | +197.8% | +176.7% | -73.3% | – | – | – | |
| – | – | – | – | – | +0.0% | +0.0% | +45.6% | -113.7% | +100.0% | +12.5% | |
| – | +69.2% | +313.2% | -93.3% | +1,114.5% | +15.4% | -67.2% | +179.0% | -77.9% | -13.6% | +156.7% | |
| – | +33.0% | +470.5% | -187.6% | – | +30.4% | -134.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.